idea collider: audio

Pick anything below and it plays in the bar at the foot of the window — and keeps playing while you go on browsing the directory.

1. 1▶Targeting the Totality of MS: Jason Tardio on Immunic’s Combined Neuroprotective and Anti-Inflammatory StrategyIDEA Collider: Innovation & Asymmetric Learning in Pharma48:51Notes
   +Listen later
2. 2▶The Future of Psychedelic Medicine: Clinical Strategy and Scaling Access.IDEA Collider: Innovation & Asymmetric Learning in Pharma49:53Notes
   +Listen later
3. 3▶The Power of the Early Narrative: Sue Wood on Strategic Biotech PositioningIDEA Collider: Innovation & Asymmetric Learning in Pharma43:22Notes
   +Listen later
4. 4▶The Execution Problem: Alex Gray and Jacqueline Poot on Pharma Decision Intelligence.IDEA Collider: Innovation & Asymmetric Learning in Pharma1:02:50Notes
   +Listen later
5. 5▶The Keytruda Blueprint: Alex Gray, David Radwaner, and Tom Brockbank on the IO RevolutionIDEA Collider: Innovation & Asymmetric Learning in Pharma20:45Notes
   +Listen later
6. 6▶Scaling TCR-T Therapies: Reagan Jarvis on Non-Viral Gene Editing and Target MappingIDEA Collider: Innovation & Asymmetric Learning in Pharma34:53Notes
   +Listen later
7. 7▶Vir Biotechnology: Marianne De Backer on Immuno-Oncology, Hepatitis Delta, and Biotech TurnaroundsIDEA Collider: Innovation & Asymmetric Learning in Pharma36:29Notes
   +Listen later
8. 8▶Building the Future of Targeted Protein Degradation Medicines with Nello MainolfiIDEA Collider: Innovation & Asymmetric Learning in Pharma41:09Notes
   +Listen later
9. 9▶AI & Competitive Intelligence in Pharma: Smarter Decision-Making with SAI MedPartnersIDEA Collider: Innovation & Asymmetric Learning in Pharma53:29Notes
   +Listen later
10. 10▶Rewriting the Future of Rare Disease: Engineered tRNA and a New Therapeutic Paradigm with Michelle WernerIDEA Collider: Innovation & Asymmetric Learning in Pharma41:27Notes
    +Listen later